# FDA Inspection 1013309 - UCB Pharma S.A. - January 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/b869769c-b1b8-4e08-b406-591c9e291b9f
Source feed: FDA_Inspections

> FDA Inspection 1013309 for UCB Pharma S.A. on January 27, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013309
- Company Name: UCB Pharma S.A.
- Inspection Date: 2017-01-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1247808 - 2024-02-01](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/75bbe824-0278-4dd2-961f-3fb1dd326b03)
- [FDA Inspection 1170317 - 2021-11-25](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/68af8621-3056-4190-a420-b538f959b83e)
- [FDA Inspection 946302 - 2015-09-11](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/4a28d1df-64ef-4aa7-b8ac-3606f8d6b0de)
- [FDA Inspection 908458 - 2014-12-16](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/761bc90e-3068-433b-a89e-881d0c63756f)
- [FDA Inspection 822144 - 2013-02-01](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/9add6b7a-66d2-4956-986f-a91f6f89b1ee)

Company: https://www.keypedia.com/companies/ucb-pharma-sa/6a03badf-6619-4125-b598-85ceebcc8c50

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c